GlassScriptPhysician profile
Doris A Yung
NPI 1730386863
$2,293.33
in general payments reported to CMS, 2019-2025
22 companies · $738 in 2025
The $738 reported for 2025 was more than what 80% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $179 · 2020: $217 · 2021: $246 · 2022: $295 · 2023: $383 · 2024: $235 · 2025: $738.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,356.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,356.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $517.54 | 2021-2025 | Ubrelvy, Skyrizi, Qulipta |
| Lilly USA, LLC | $264.05 | 2019-2025 | Mounjaro, Zepbound, Trulicity |
| Novo Nordisk INC | $229.20 | 2019-2025 | Ozempic, Rybelsus |
| Merck Sharp & Dohme LLC | $202.28 | 2019-2025 | Gardasil 9, M-M-R II, Vaxneuvance |
| Pfizer INC. | $165.91 | 2020-2025 | |
| Cranial Technologies, INC | $155.02 | 2019-2025 | Doc Band |
| Sanofi Pasteur INC. | $124.38 | 2025 | |
| Radius Health, INC. | $110.91 | 2019-2023 | |
| Amarin Pharma, INC. | $86.85 | 2020-2021 | |
| Glaxosmithkline, LLC. | $69.57 | 2022-2024 | Trelegy Ellipta, Shingrix, Arexvy |
| Kowa Pharmaceuticals America, INC. | $60.65 | 2023-2025 | Seglentis, Zoryve, Livalo |
| Hologic Sales and Service, LLC | $58.15 | 2021-2025 | Aptima |
| Sanofi-Aventis U.S. LLC | $41.29 | 2019-2021 | |
| Amgen INC. | $35.40 | 2022-2023 | Repatha, Otezla |
| Bayer Healthcare Pharmaceuticals INC. | $30.76 | 2025 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $27.50 | 2021 | |
| Xeris Pharmaceuticals, INC. | $24.76 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $23.20 | 2025 | Caplyta |
| Dynavax Technologies Corporation | $19.43 | 2022 | |
| Organon LLC | $15.79 | 2021 | |
| Coopersurgical, INC. | $15.63 | 2025 | Paragard T 380a |
| Medtronic, INC. | $15.06 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Doris Yung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.